Document is current
Any future updates will be listed below
-
Authors
Strandberg, Timo E.
Benetos, Athanase
- License Information
-
More Information
Article History
First Online: 11 February 2025
Declarations
:
: T Strandberg: Educational, research and consultative co-operation with several companies (incl Amgen, Novartis, Orion Pharma, Sankyo) marketing lipid-lowering drugs. Chairperson of the dyslipidemia guideline group in Finland. A Benetos: No disclosures for this article.
: This article does not contain any studies with human participants or animals performed by any of the authors.
Free to read: This content has been made available to all.
